News
SNPHF
10.99
NaN%
--
Santen Authorizes ¥35 Billion Share Buyback
TipRanks · 11/05 07:06
Santen Announces Increase in Stake by Major Shareholder Silchester
TipRanks · 10/27 02:22
Santen’s Chinese Ophthalmic JV Moves to Bankruptcy After Liquidation Efforts Stall
TipRanks · 10/16 07:52
Santen Completes Treasury Share Disposal for Performance-Linked Executive Stock Plan
TipRanks · 09/30 07:33
Santen to Dispose of Treasury Shares for Performance-Linked Executive Stock Plan
TipRanks · 09/03 07:24
Santen boosts profits in Q1 and maintains upbeat full-year outlook
TipRanks · 08/06 07:21
Santen Pharmaceutical Co (SNPHF) Gets a Buy from UBS
TipRanks · 07/14 12:46
Santen Pharmaceutical Lifts Earnings and Dividends, Signals Growth for FY2027
TipRanks · 05/12 07:59
Santen Pharmaceutical Posts Lower Nine-Month Earnings but Raises Annual Dividend and Maintains Outlook
TipRanks · 02/05 07:05
More
Webull provides a variety of real-time SNPHF stock news. You can receive the latest news about Santen Pharmaceutical Co Ltd through multiple platforms. This information may help you make smarter investment decisions.
About SNPHF
Santen Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, and sale of pharmaceuticals. The Company engages in global research and development, manufacture, sale, and marketing of pharmaceuticals in the ophthalmology field. The Company engages in prescription pharmaceuticals, over-the-counter pharmaceuticals, medical devices, and other businesses. The Company operates in Japan, Asia, Europe, the Middle East, and Africa (EMEA), China, and other regions.